Lev A. Krichevskiy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lev A. Krichevskiy has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- V. Yu. Rybakov
S. S. Yudin City Clinical Hospital
10 shared publications - Igor A. Kozlov
M. F. Vladimirsky Moscow Regional Research Clinical Institute
7 shared publications - Artem A. Dvoryadkin
S.S. Yudin City Clinical Hospital, Moscow, Russia
6 shared publications - Dmitry A. Polyakov
S.S. Yudin City Clinical Hospital, Moscow, Russia
6 shared publications - Olga Viktorovna Ignatenko
Sergey Yudin City Clinical Hospital, Moscow, Russia;Russian Medical Academy of Continuous Professional Education, Moscow, Russia;Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
5 shared publications - Anastasia Doronenkova
S.S. Yudin City Clinical Hospital, Moscow, Russia
4 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4,p. 158-172
The role of cardiopulmonary bypass duration and laboratory parameters in predicting postoperative complications in cardiac surgery: a retrospective study
INTRODUCTION: Complications related to cardiopulmonary bypass (CPB) remain an urgent problem in cardiac surgery. OBJECTIVE: To develop an algorithm for predicting CPB complications based on its duration and laboratory monitoring data. MATERIALS AND METHODS: A retrospective analysis of 150 patients (86 men, 64 women) aged 65 ± 7 years who underwent elective surgery with CPB was performed. Biomarkers and blood circulation parameters were determined before incision and after CPB. The postoperative period was considered complicated in the presence of a combined endpoint: death, mechanical ventilation > 12 h, renal replacement therapy (RRT), acute encephalopathy, or non-drug depression of consciousness. RESULTS: The combined primary endpoint was registered in 34 (22.7 %) patients. The threshold value of CPB duration associated with complications was 132 min (AUC 0.734; sensitivity 52 %, specificity 93 %; p < 0.0001). In patients with CPB ≥ 132 min (n = 35), CPB duration lost prognostic significance; however, lactate and leukocyte levels after CPB differed significantly between patients with complicated and uncomplicated courses. Their combination in a logistic regression model provided high prognostic efficacy (AUC 0.936). For practical use, an integral index — the product of lactate and leukocytes after CPB — was proposed. A threshold value > 72 units predicted the combined primary endpoint with a sensitivity of 100 % and specificity of 81 % (AUC 0.909). In patients with an index > 72 units, mechanical ventilation was significantly longer (55 ± 10 vs 11 ± 2 h; log-rank p < 0.0001). CONCLUSIONS: CPB duration exceeding 132 min is a significant but insufficient factor for individual prognosis. In patients with prolonged CPB, the post-perfusion product of lactate level and leukocyte count is of decisive prognostic value and may be used for early risk stratification.
- 31 October 2026
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4,p. 158-172
Open AccessThe role of cardiopulmonary bypass duration and laboratory parameters in predicting postoperative complications in cardiac surgery: a retrospective study
INTRODUCTION: Complications related to cardiopulmonary bypass (CPB) remain an urgent problem in cardiac surgery. OBJECTIVE: To develop an algorithm for predicting CPB complications based on its duration and laboratory monitoring data. MATERIALS AND METHODS: A retrospective analysis of 150 patients (86 men, 64 women) aged 65 ± 7 years who underwent elective surgery with CPB was performed. Biomarkers and blood circulation parameters were determined before incision and after CPB. The postoperative period was considered complicated in the presence of a combined endpoint: death, mechanical ventilation > 12 h, renal replacement therapy (RRT), acute encephalopathy, or non-drug depression of consciousness. RESULTS: The combined primary endpoint was registered in 34 (22.7 %) patients. The threshold value of CPB duration associated with complications was 132 min (AUC 0.734; sensitivity 52 %, specificity 93 %; p < 0.0001). In patients with CPB ≥ 132 min (n = 35), CPB duration lost prognostic significance; however, lactate and leukocyte levels after CPB differed significantly between patients with complicated and uncomplicated courses. Their combination in a logistic regression model provided high prognostic efficacy (AUC 0.936). For practical use, an integral index — the product of lactate and leukocytes after CPB — was proposed. A threshold value > 72 units predicted the combined primary endpoint with a sensitivity of 100 % and specificity of 81 % (AUC 0.909). In patients with an index > 72 units, mechanical ventilation was significantly longer (55 ± 10 vs 11 ± 2 h; log-rank p < 0.0001). CONCLUSIONS: CPB duration exceeding 132 min is a significant but insufficient factor for individual prognosis. In patients with prolonged CPB, the post-perfusion product of lactate level and leukocyte count is of decisive prognostic value and may be used for early risk stratification.
- Open Access
- 23 October 2026
- Published by Science Publishing Group in International Journal of Clinical and Experimental Medical Sciences
- Vol. 12 (5) , 82-95
Prognostic Role of Nucleosomes Containing Histones of the H3.1 Type in Septic Shock: Results of a Prospective Study
Cell-free DNA (cfDNA) and neutrophil extracellular traps (NETs), specifically marked by histone type 3.1, play a dual pathogenic role in sepsis by reflecting cellular damage and directly exacerbating tissue injury, highlighting their clinical relevance for extracorporeal elimination therapies. To evaluate their prognostic value, we conducted a prospective, single-center observational study quantifying nucleosomes containing histones of the H3.1 type (Nu.H3.1) in 52 adult patients with septic shock admitted to an intensive care unit between August 2023 and May 2024. The cohort (64% male) had a mean SOFA score of 10±4 and an APACHE II score of 22±7. The H3.1-nuc concentration was 4658 ± 3962 ng/mL, and the median cfDNA level was 3041 (876–7815) ng/mL. Statistical analysis revealed that Nu.H3.1 levels significantly and positively correlated with cfDNA (r=0.67; p=0.0001), serum lactate (r=0.4; p=0.004), and SOFA scores (r=0.41; p=0.002). Furthermore, Nu.H3.1 demonstrated significant predictive performance for both 28-day mortality (AUC=0.68; 95% CI: 0.53–0.84; p=0.037) and the development of acute kidney injury (AKI) (AUC=0.74; 95% CI: 0.57–0.90; p=0.014). In conclusion, Nu.H3.1 serves as an independent predictor of adverse outcomes in septic shock, with established threshold values identifying patients at high risk for mortality and AKI. These findings suggest that Nu.H3.1 is a promising biomarker for clinical risk stratification and for substantiating indications for the extracorporeal elimination of toxic DNA-associated structures from the systemic circulation.
- 23 October 2026
- Published by Science Publishing Group in International Journal of Clinical and Experimental Medical Sciences
- Vol. 12 (5) , 82-95
Open AccessPrognostic Role of Nucleosomes Containing Histones of the H3.1 Type in Septic Shock: Results of a Prospective Study
Cell-free DNA (cfDNA) and neutrophil extracellular traps (NETs), specifically marked by histone type 3.1, play a dual pathogenic role in sepsis by reflecting cellular damage and directly exacerbating tissue injury, highlighting their clinical relevance for extracorporeal elimination therapies. To evaluate their prognostic value, we conducted a prospective, single-center observational study quantifying nucleosomes containing histones of the H3.1 type (Nu.H3.1) in 52 adult patients with septic shock admitted to an intensive care unit between August 2023 and May 2024. The cohort (64% male) had a mean SOFA score of 10±4 and an APACHE II score of 22±7. The H3.1-nuc concentration was 4658 ± 3962 ng/mL, and the median cfDNA level was 3041 (876–7815) ng/mL. Statistical analysis revealed that Nu.H3.1 levels significantly and positively correlated with cfDNA (r=0.67; p=0.0001), serum lactate (r=0.4; p=0.004), and SOFA scores (r=0.41; p=0.002). Furthermore, Nu.H3.1 demonstrated significant predictive performance for both 28-day mortality (AUC=0.68; 95% CI: 0.53–0.84; p=0.037) and the development of acute kidney injury (AKI) (AUC=0.74; 95% CI: 0.57–0.90; p=0.014). In conclusion, Nu.H3.1 serves as an independent predictor of adverse outcomes in septic shock, with established threshold values identifying patients at high risk for mortality and AKI. These findings suggest that Nu.H3.1 is a promising biomarker for clinical risk stratification and for substantiating indications for the extracorporeal elimination of toxic DNA-associated structures from the systemic circulation.
- 15 October 2026
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 5
Del Nido cardioplegia vs. traditional blood cardioplegia in coronary artery bypass grafting
Objective. To compare efficacy of Del Nido cardioplegia (DNC) versus conventional Calafiore warm blood cardioplegia (CBC) in patients undergoing isolated on-pump coronary artery bypass grafting (CABG). Material and methods. A single-center, randomized, prospective trial enrolled 50 patients (30 male, 20 female) aged 41–87 years (mean 62.2±8.7) scheduled for on-pump CABG. Patients were randomized into two groups: the DNC group (n=25) received a single dose of Del Nido cardioplegia, while the CBC group (n=25) received intermittent Calafiore warm blood cardioplegia. Results. The DNC group demonstrated significantly shorter cardiopulmonary bypass time (73±18 vs. 84±14 min; p=0.023) and aortic cross-clamping time (44.5±13 vs. 52±12 min; p=0.021). Furthermore, peak postoperative MB fraction of creatine phosphokinase was significantly lower in this group (32±14 vs. 42±17 U/L; p=0.035). There was no significant between-group difference in postoperative ICU-stay (p>0.1). Conclusion. Del Nido cardioplegia provides effective myocardial protection in on-pump CABG. Its advantages include a single dose and myocardial protection comparable to that for conventional blood cardioplegia.
- 15 October 2026
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 5
Del Nido cardioplegia vs. traditional blood cardioplegia in coronary artery bypass grafting
Objective. To compare efficacy of Del Nido cardioplegia (DNC) versus conventional Calafiore warm blood cardioplegia (CBC) in patients undergoing isolated on-pump coronary artery bypass grafting (CABG). Material and methods. A single-center, randomized, prospective trial enrolled 50 patients (30 male, 20 female) aged 41–87 years (mean 62.2±8.7) scheduled for on-pump CABG. Patients were randomized into two groups: the DNC group (n=25) received a single dose of Del Nido cardioplegia, while the CBC group (n=25) received intermittent Calafiore warm blood cardioplegia. Results. The DNC group demonstrated significantly shorter cardiopulmonary bypass time (73±18 vs. 84±14 min; p=0.023) and aortic cross-clamping time (44.5±13 vs. 52±12 min; p=0.021). Furthermore, peak postoperative MB fraction of creatine phosphokinase was significantly lower in this group (32±14 vs. 42±17 U/L; p=0.035). There was no significant between-group difference in postoperative ICU-stay (p>0.1). Conclusion. Del Nido cardioplegia provides effective myocardial protection in on-pump CABG. Its advantages include a single dose and myocardial protection comparable to that for conventional blood cardioplegia.
- 1 May 2026
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 40 (10) , 3212-3219
The Predictive Value of Combined Lactate and Leukocyte Levels for Postoperative Morbidity after Prolonged Cardiopulmonary Bypass
- 1 May 2026
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 40 (10) , 3212-3219
The Predictive Value of Combined Lactate and Leukocyte Levels for Postoperative Morbidity after Prolonged Cardiopulmonary Bypass
- Open Access
- 31 January 2026
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 1,p. 58-72
Prognostic value of histone H3.1-containing nucleosomes in septic shock: a prospective observational study
INTRODUCTION: Cell free DNA (cfDNA) is of considerable interest as a marker and pathogenesis factor in sepsis. Two processes are sources of cfDNA: cell death with the ingress of the contents of the cell nucleus into the bloodstream and the release of extracellular neutrophil traps (NETs). The marker of NETs formation is histone type 3.1. CfDNA and NETs in sepsis act in a dual role — they characterize the degree of cellular damage and the intensity of the inflammatory response, and at the same time they are etiological agents of these two processes. OBJECTIVE: This study aimed to analyze the level of nucleosomes containing histones of the H3.1 type (nucleosomes H3.1) in patients with septic shock, and the correlation of the nucleosome level with clinical and laboratory data of patients, especially the risk of developing significant clinical events. MATERIALS AND METHODS: The prospective single-center observational study included 52 patients with septic shock (Sepsis-3 criteria), admitted to the intensive care unit. RESULTS: The total number of patients was n = 52, with the severity score SOFA 10 ± 4. The median concentration of Nu.H3.1 was 4658 ± 3962 ng/ml, cfDNA — 3041 (876–7815) ng/ml. The most significant correlations of Nu.H3.1 were recorded with the lactate level (rxy = 0.4; p = 0.004) and the SOFA scale (rxy = 0.41; p = 0.002). For Nu.H3.1, a significant association with 28-day mortality and AKI was determined. CONCLUSIONS: The study showed that the marker of NETs formation — the level of Nu.H3.1 is an independent predictor of mortality and the development of AKI in septic shock, its threshold concentration was identified. It was associated with a risks of these significant clinical events. So this level can be considered as a laboratory benchmark in determining the indications for extracorporeal elimination of DNA-containing structures from the bloodstream. Objective. This study aimed to analyze the level of nucleosomes containing histones of the H3.1 type (nucleosomes H3.1) in patients with septic shock, and the correlation of the nucleosome level with clinical and laboratory data of patients, especially the risk of developing acute kidney injury (AKI) and 28-day mortality. Material and methods. The prospective single-center observational pilot study included 52 patients over 18 years old with septic shock (Sepsis-3 criteria), admitted to the intensive care unit of the State Healthcare Institution "City Clinical Hospital named after S.S. Yudin" between August 2023 and May 2024. Results. The total number of patients included in the study was n=52 (64% men, 36% women) aged 52.1 ± 17.3 years, with the severity scores SOFA 10±4 and Apache II - 22±7 points, respectively. The median concentration of Nu.H3.1 was 4658± 3962 ng/ml, cfDNA - 3041 (876-7815.0) ng/ml. The correlation between cfDNA and Nu.H3.1 had a noticeable direct relationship (r xy = 0.67, p = 0.0001). The most significant correlations of Nu.H3.1 were recorded with the lactate level (r xy = 0.4, p = 0.004) and the SOFA scale (r xy = 0.41, p = 0.002). For Nu.H3.1, a significant association with 28-day mortality (AUC 0.68, 95% CI (0.53-0.84) p = 0.037) and AKI (AUC 0.74, 95% CI (0.57-0.90) p = 0.014) was determined. The OR for the development of AKI at a concentration of Nu.H3.1> 2731 ng / ml was 6.0 (95% CI: 1.6-26.0, p < 0.018), sensitivity, specificity - 67% and 75%, respectively. For 28-day mortality at a concentration of Nu.H3.1 > 2731 ng / ml, the OR was 4.4 (95% CI: 1.2-15.6; p = 0.03), sensitivity, specificity - 67 and 79%, respectively. Conclusion. The study showed that the marker of NETs formation – the level of Nu.H3.1 is an independent predictor of mortality and the development of AKI in septic shock, its threshold concentration was identified. It was associated with a risks of these significant clinical events. So this level can be considered as a laboratory benchmark in determining the indications for extracorporeal elimination of DNA-containing structures from the bloodstream.
- 31 January 2026
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 1,p. 58-72
Open AccessPrognostic value of histone H3.1-containing nucleosomes in septic shock: a prospective observational study
INTRODUCTION: Cell free DNA (cfDNA) is of considerable interest as a marker and pathogenesis factor in sepsis. Two processes are sources of cfDNA: cell death with the ingress of the contents of the cell nucleus into the bloodstream and the release of extracellular neutrophil traps (NETs). The marker of NETs formation is histone type 3.1. CfDNA and NETs in sepsis act in a dual role — they characterize the degree of cellular damage and the intensity of the inflammatory response, and at the same time they are etiological agents of these two processes. OBJECTIVE: This study aimed to analyze the level of nucleosomes containing histones of the H3.1 type (nucleosomes H3.1) in patients with septic shock, and the correlation of the nucleosome level with clinical and laboratory data of patients, especially the risk of developing significant clinical events. MATERIALS AND METHODS: The prospective single-center observational study included 52 patients with septic shock (Sepsis-3 criteria), admitted to the intensive care unit. RESULTS: The total number of patients was n = 52, with the severity score SOFA 10 ± 4. The median concentration of Nu.H3.1 was 4658 ± 3962 ng/ml, cfDNA — 3041 (876–7815) ng/ml. The most significant correlations of Nu.H3.1 were recorded with the lactate level (rxy = 0.4; p = 0.004) and the SOFA scale (rxy = 0.41; p = 0.002). For Nu.H3.1, a significant association with 28-day mortality and AKI was determined. CONCLUSIONS: The study showed that the marker of NETs formation — the level of Nu.H3.1 is an independent predictor of mortality and the development of AKI in septic shock, its threshold concentration was identified. It was associated with a risks of these significant clinical events. So this level can be considered as a laboratory benchmark in determining the indications for extracorporeal elimination of DNA-containing structures from the bloodstream. Objective. This study aimed to analyze the level of nucleosomes containing histones of the H3.1 type (nucleosomes H3.1) in patients with septic shock, and the correlation of the nucleosome level with clinical and laboratory data of patients, especially the risk of developing acute kidney injury (AKI) and 28-day mortality. Material and methods. The prospective single-center observational pilot study included 52 patients over 18 years old with septic shock (Sepsis-3 criteria), admitted to the intensive care unit of the State Healthcare Institution "City Clinical Hospital named after S.S. Yudin" between August 2023 and May 2024. Results. The total number of patients included in the study was n=52 (64% men, 36% women) aged 52.1 ± 17.3 years, with the severity scores SOFA 10±4 and Apache II - 22±7 points, respectively. The median concentration of Nu.H3.1 was 4658± 3962 ng/ml, cfDNA - 3041 (876-7815.0) ng/ml. The correlation between cfDNA and Nu.H3.1 had a noticeable direct relationship (r xy = 0.67, p = 0.0001). The most significant correlations of Nu.H3.1 were recorded with the lactate level (r xy = 0.4, p = 0.004) and the SOFA scale (r xy = 0.41, p = 0.002). For Nu.H3.1, a significant association with 28-day mortality (AUC 0.68, 95% CI (0.53-0.84) p = 0.037) and AKI (AUC 0.74, 95% CI (0.57-0.90) p = 0.014) was determined. The OR for the development of AKI at a concentration of Nu.H3.1> 2731 ng / ml was 6.0 (95% CI: 1.6-26.0, p < 0.018), sensitivity, specificity - 67% and 75%, respectively. For 28-day mortality at a concentration of Nu.H3.1 > 2731 ng / ml, the OR was 4.4 (95% CI: 1.2-15.6; p = 0.03), sensitivity, specificity - 67 and 79%, respectively. Conclusion. The study showed that the marker of NETs formation – the level of Nu.H3.1 is an independent predictor of mortality and the development of AKI in septic shock, its threshold concentration was identified. It was associated with a risks of these significant clinical events. So this level can be considered as a laboratory benchmark in determining the indications for extracorporeal elimination of DNA-containing structures from the bloodstream.
- Open Access
- 31 January 2026
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 1,p. 73-85
Combined extracorporeal therapy with plasma exchange and hemoadsorbtion in septic shock: a randomized controlled study
INTRODUCTION: The consistently high mortality rate associated with septic shock leads to the search for new treatment strategies. OBJECTIVE: The aim of our study was to analyze the efficacy and safety of the combined use of plasma exchange and hemosorbtion in septic shock. MATERIALS AND METHODS: A total of 64 patients with septic shock who were hospitalized in the ICU of the S.S. Yudin Hospital in Moscow from January 2023 to January 2024 were prospectively examined. The combined extracorporeal therapy group included patients who underwent two combinations of procedures depending on the level of endotoxinactivity (endotoxin activity assay — EAA): with EAA greater than 0.6 — plasma exchange + LPS hemosorbtion, with EAA less than 0.6 — plasma exchange + cytokine hemosorption. The controlgroup included patients with standard sepsis therapy. Clinical and laboratory parameters, duration and outcomes of intensive care were recorded. RESULTS: The study group (ET, n = 31), compared with the control group (n = 33), was characterized by a significant (p < 0.05) reduction of organ disfunction according to the Sequential Organ Failure Assessment, and Acute Physiology and Chronic Health Evaluation II, scales, a decrease of systemic inflammation markers, and an increase of IgG level within 72 hours after inclusion in the study. Hospital mortality was lower in the ET group than in the control group 32 and 58 %, respectively: OR 0.35; 95% CI 0.12–0.98; p = 0.023. CONCLUSIONS: Combined extracorporeal therapy is an effective treatment strategy for septic shock, improving the results of its intensive care.
- 31 January 2026
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 1,p. 73-85
Open AccessCombined extracorporeal therapy with plasma exchange and hemoadsorbtion in septic shock: a randomized controlled study
INTRODUCTION: The consistently high mortality rate associated with septic shock leads to the search for new treatment strategies. OBJECTIVE: The aim of our study was to analyze the efficacy and safety of the combined use of plasma exchange and hemosorbtion in septic shock. MATERIALS AND METHODS: A total of 64 patients with septic shock who were hospitalized in the ICU of the S.S. Yudin Hospital in Moscow from January 2023 to January 2024 were prospectively examined. The combined extracorporeal therapy group included patients who underwent two combinations of procedures depending on the level of endotoxinactivity (endotoxin activity assay — EAA): with EAA greater than 0.6 — plasma exchange + LPS hemosorbtion, with EAA less than 0.6 — plasma exchange + cytokine hemosorption. The controlgroup included patients with standard sepsis therapy. Clinical and laboratory parameters, duration and outcomes of intensive care were recorded. RESULTS: The study group (ET, n = 31), compared with the control group (n = 33), was characterized by a significant (p < 0.05) reduction of organ disfunction according to the Sequential Organ Failure Assessment, and Acute Physiology and Chronic Health Evaluation II, scales, a decrease of systemic inflammation markers, and an increase of IgG level within 72 hours after inclusion in the study. Hospital mortality was lower in the ET group than in the control group 32 and 58 %, respectively: OR 0.35; 95% CI 0.12–0.98; p = 0.023. CONCLUSIONS: Combined extracorporeal therapy is an effective treatment strategy for septic shock, improving the results of its intensive care.
- 30 January 2026
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 14 (4)
The Role of Extracellular DNA Among Predictors of Hospital Mortality in Patients with Septic Shock
Introduction. Extracellular DNA (exDNA) is a well-known but poorly understood mediator of sepsis. The aim was to investigate the role of exDNA as an independent predictor of mortality and as a marker of unfavorable clinical phenotype for patients with septic shock. Material and methods. The patients over the age of 18 with septic shock (Sepsis-3 criteria) who were admitted to the intensive care unit of the S.S. Yudin City Clinical Hospital between August 2023 and May 2024 were included in a prospective observational study. Results. Total of fifty-two patients (64% men, 36% women) aged 52.1 ± 17.3 years, with severity of the condition on the SOFA score 10±4 and APACHE II score — 22±7 were included. The exDNA concentration was 3041 (876–7815.0) ng/ml. For exDNA, a significant (p=0,031) association with 28-day mortality was determined (AUC 0.69, 95% CI (0.54–0.84)), and a cut-off point >1893 ng/ml was identified, at which the OR of the hospital death corresponded to 4.3 (95% CI 1.3–15.1, p=0.03). The dependence of the risk of death on the concentration of exDNA (1893 ng/ml), estimated using the Mantel-Cox log-rank test, was statistically significant (p=0.028). The median survival time in the exDNA group >1893 ng/ml was 7 days, and for exDNA levels 1893 ng/ml in patients with septic shock were the level of mixed venous blood lactate (OR 2.0; 95% CI [1.02, 3.92], p=0.044) and SOFA score (OR 1.23; 95% CI [1.02, 1.47], p=0.029). Conclusion. The exDNA level is an independent predictor of mortality in septic shock. Its cut-off point of 1893 ng/ml could be considered as an indication for extracorporeal elimination of exDNA. Point of care laboratory markers of a significant increase in the blood concentration of exDNA were also identified and could be considered as a guide to an intensive care.
- 30 January 2026
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 14 (4)
The Role of Extracellular DNA Among Predictors of Hospital Mortality in Patients with Septic Shock
Introduction. Extracellular DNA (exDNA) is a well-known but poorly understood mediator of sepsis. The aim was to investigate the role of exDNA as an independent predictor of mortality and as a marker of unfavorable clinical phenotype for patients with septic shock. Material and methods. The patients over the age of 18 with septic shock (Sepsis-3 criteria) who were admitted to the intensive care unit of the S.S. Yudin City Clinical Hospital between August 2023 and May 2024 were included in a prospective observational study. Results. Total of fifty-two patients (64% men, 36% women) aged 52.1 ± 17.3 years, with severity of the condition on the SOFA score 10±4 and APACHE II score — 22±7 were included. The exDNA concentration was 3041 (876–7815.0) ng/ml. For exDNA, a significant (p=0,031) association with 28-day mortality was determined (AUC 0.69, 95% CI (0.54–0.84)), and a cut-off point >1893 ng/ml was identified, at which the OR of the hospital death corresponded to 4.3 (95% CI 1.3–15.1, p=0.03). The dependence of the risk of death on the concentration of exDNA (1893 ng/ml), estimated using the Mantel-Cox log-rank test, was statistically significant (p=0.028). The median survival time in the exDNA group >1893 ng/ml was 7 days, and for exDNA levels 1893 ng/ml in patients with septic shock were the level of mixed venous blood lactate (OR 2.0; 95% CI [1.02, 3.92], p=0.044) and SOFA score (OR 1.23; 95% CI [1.02, 1.47], p=0.029). Conclusion. The exDNA level is an independent predictor of mortality in septic shock. Its cut-off point of 1893 ng/ml could be considered as an indication for extracorporeal elimination of exDNA. Point of care laboratory markers of a significant increase in the blood concentration of exDNA were also identified and could be considered as a guide to an intensive care.
- Open Access
- 31 October 2025
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4,p. 148-157
Early noninvasive assessment of the severity of myocardial dysfunction in sepsis: a retrospective observational study
INTRODUCTION: Early and rapid assessment of the severity and prognosis of severe sepsis is an essential part of sepsis intensive care. It determines the pace and intensity of treatment measures and the routing process of patients in the first hours after hospitalization. OBJECTIVE: To identify early, prognostically significant signs of severe myocardial dysfunction in abdominal sepsis. MATERIALS AND METHODS: A total of 40 patients with abdominal sepsis were retrospectively examined. General clinical and laboratory parameters, circulatory parameters, echocardiography data, and hospitalization outcomes were recorded. Depending on the outcome, patients were divided into 2 groups. To assess the separating ability of independent variables, ROC analysis was performed, including only the indicators that differed between the groups. RESULTS: Predictors of unfavorable outcome of sepsis were high heart rate (HR; AUC = 0.7, cut-off > 93, 95% CI = 0.524–0.844, p = 0.027), decreased left ventricular ejection fraction (LVEF, AUC = 0.68, cut-off < 52 %, 95% CI = 0.495–0.822, p = 0.027), SOFA scale value (AUC = 0.69, cut-off > 6, 95% CI = 0.519–0.825, p = 0.034) and lactate level (AUC = 0.87, cut-off > 3.74, 95% CI = 0.706–0.968, p = 0.0001). A new index was identified — the ratio of HR to LVEF (HR/LVEF), which has advantages over standard parameters. The proposed indicator significantly (p = 0.0003) differed between the groups (1.29 [1.16–1.53] min–1 with a favorable outcome and 1.87 [1.55–2.49] min–1 with an unfavorable outcome). When analyzing the ROC curve of the effect of this index on the treatment outcome, the area was 0.86 (95 % CI: 0.696–0.954), p < 0.0001; cut-off value > 1.61 min–1 (sensitivity — 75 %, specificity — 90 %). CONCLUSIONS: Early signs of an unfavorable course of abdominal sepsis are tachycardia, decreased LVEF, increased SOFA scale values, but the most reliable (p < 0.001) is hyperlactatemia. Calculating the HR/LVEF ratio allows us to qualitatively improve the information content of echocardiographic screening.
- 31 October 2025
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4,p. 148-157
Open AccessEarly noninvasive assessment of the severity of myocardial dysfunction in sepsis: a retrospective observational study
INTRODUCTION: Early and rapid assessment of the severity and prognosis of severe sepsis is an essential part of sepsis intensive care. It determines the pace and intensity of treatment measures and the routing process of patients in the first hours after hospitalization. OBJECTIVE: To identify early, prognostically significant signs of severe myocardial dysfunction in abdominal sepsis. MATERIALS AND METHODS: A total of 40 patients with abdominal sepsis were retrospectively examined. General clinical and laboratory parameters, circulatory parameters, echocardiography data, and hospitalization outcomes were recorded. Depending on the outcome, patients were divided into 2 groups. To assess the separating ability of independent variables, ROC analysis was performed, including only the indicators that differed between the groups. RESULTS: Predictors of unfavorable outcome of sepsis were high heart rate (HR; AUC = 0.7, cut-off > 93, 95% CI = 0.524–0.844, p = 0.027), decreased left ventricular ejection fraction (LVEF, AUC = 0.68, cut-off < 52 %, 95% CI = 0.495–0.822, p = 0.027), SOFA scale value (AUC = 0.69, cut-off > 6, 95% CI = 0.519–0.825, p = 0.034) and lactate level (AUC = 0.87, cut-off > 3.74, 95% CI = 0.706–0.968, p = 0.0001). A new index was identified — the ratio of HR to LVEF (HR/LVEF), which has advantages over standard parameters. The proposed indicator significantly (p = 0.0003) differed between the groups (1.29 [1.16–1.53] min–1 with a favorable outcome and 1.87 [1.55–2.49] min–1 with an unfavorable outcome). When analyzing the ROC curve of the effect of this index on the treatment outcome, the area was 0.86 (95 % CI: 0.696–0.954), p < 0.0001; cut-off value > 1.61 min–1 (sensitivity — 75 %, specificity — 90 %). CONCLUSIONS: Early signs of an unfavorable course of abdominal sepsis are tachycardia, decreased LVEF, increased SOFA scale values, but the most reliable (p < 0.001) is hyperlactatemia. Calculating the HR/LVEF ratio allows us to qualitatively improve the information content of echocardiographic screening.
- 1 September 2025
- Published by Alfmed LLC in Medical alphabet
- No. 18,p. 23-32
Prognostic significance of the preoperative level of biomarker NT-proBNP in myocardial revascularization with cardiopulmonary bypass (pilot study)
The objective: to study the relationship between the preoperative blood levels of the N-terminal segment of B-type natriuretic peptide precursor (NT-proBNP) and echocardiographic and pulmonary artery catheter (PAC) data before and after on-pump coronary artery bypass grafting (CABG), and to evaluate the biomarker as a predictor of postoperative myocardial dysfunction.Material and methods. The study involved 63 patients aged 51[39–64] years with ischemic heart disease who underwent CABG. NT-proBNP blood level was determined before surgery. PAC and transesophageal echocardiography (TEE) data were analyzed at the stages: I – after anesthesia induction, II – at the end of surgery. Correlation analysis, logistic regression with calculation of odds ratio (OR) and 95% confidence interval (95% CI) and ROC analysis with calculation of area under ROC curve (AUC) were used.Results. The median preoperative NT-proBNP blood level was 418.3[225.5–950.45] pg/mL. At stage I, NT-proBNP moderately correlated with mean and wedge pulmonary artery pressures, as well as with TEE parameters of the left ventricle (LV) sizes and function. At stage II, the biomarker moderately correlated only with TEE parameters. NT-proBNP >579 pg/mL was a predictor of LV area contraction fraction (LVACF) 605 pg/mL was a predictor of LV end-systolic area index (LVESAI) >9 cm2 / m2 (OR1.0015, 95% CI 1.0004–1.0026, p=0.008, AUC0.834) at the end of surgery. NT-proBNP10 (OR1.0016, 95% CI 1.0005–1.0026, p=0.003, AUC0.808), intra-aortic balloon pumping (IABP) (OR1.0019, 95% CI 1.0007–1.0030, p=0.001, AUC0.914) and intensive care unit length of stay >24 hours (OR1.0020, 95% CI 1.0007–1.0032, p=0.002, AUC0.771). NTproBNP >953 pg/mL was a predictor of the refractory heart failure (RHF) (OR1.0017, 95% CI 1.0006–1.0027, p=0.003, AUC0.866).Conclusion. In 50.8% of patients before on-pump CABG, NT-proBNP blood level exceeded the upper limit of normal and varied within the range of 355–3232 pg/ml. NT-proBNP values moderately correlated with perioperative TEE parameters. There were no persistent correlations with PAC data. Preoperative NT-proBNP values of about 600 pg/mL were predictors of LVESAI >9 cm2 /m2 (AUC0,834) and LVACF 950 pg/mL was a predictor of RHF after on-pump CABG (AUC0.866).
- 1 September 2025
- Published by Alfmed LLC in Medical alphabet
- No. 18,p. 23-32
Prognostic significance of the preoperative level of biomarker NT-proBNP in myocardial revascularization with cardiopulmonary bypass (pilot study)
The objective: to study the relationship between the preoperative blood levels of the N-terminal segment of B-type natriuretic peptide precursor (NT-proBNP) and echocardiographic and pulmonary artery catheter (PAC) data before and after on-pump coronary artery bypass grafting (CABG), and to evaluate the biomarker as a predictor of postoperative myocardial dysfunction.Material and methods. The study involved 63 patients aged 51[39–64] years with ischemic heart disease who underwent CABG. NT-proBNP blood level was determined before surgery. PAC and transesophageal echocardiography (TEE) data were analyzed at the stages: I – after anesthesia induction, II – at the end of surgery. Correlation analysis, logistic regression with calculation of odds ratio (OR) and 95% confidence interval (95% CI) and ROC analysis with calculation of area under ROC curve (AUC) were used.Results. The median preoperative NT-proBNP blood level was 418.3[225.5–950.45] pg/mL. At stage I, NT-proBNP moderately correlated with mean and wedge pulmonary artery pressures, as well as with TEE parameters of the left ventricle (LV) sizes and function. At stage II, the biomarker moderately correlated only with TEE parameters. NT-proBNP >579 pg/mL was a predictor of LV area contraction fraction (LVACF) 605 pg/mL was a predictor of LV end-systolic area index (LVESAI) >9 cm2 / m2 (OR1.0015, 95% CI 1.0004–1.0026, p=0.008, AUC0.834) at the end of surgery. NT-proBNP10 (OR1.0016, 95% CI 1.0005–1.0026, p=0.003, AUC0.808), intra-aortic balloon pumping (IABP) (OR1.0019, 95% CI 1.0007–1.0030, p=0.001, AUC0.914) and intensive care unit length of stay >24 hours (OR1.0020, 95% CI 1.0007–1.0032, p=0.002, AUC0.771). NTproBNP >953 pg/mL was a predictor of the refractory heart failure (RHF) (OR1.0017, 95% CI 1.0006–1.0027, p=0.003, AUC0.866).Conclusion. In 50.8% of patients before on-pump CABG, NT-proBNP blood level exceeded the upper limit of normal and varied within the range of 355–3232 pg/ml. NT-proBNP values moderately correlated with perioperative TEE parameters. There were no persistent correlations with PAC data. Preoperative NT-proBNP values of about 600 pg/mL were predictors of LVESAI >9 cm2 /m2 (AUC0,834) and LVACF 950 pg/mL was a predictor of RHF after on-pump CABG (AUC0.866).
- 8 August 2025
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 4
Erector spinae plane block for tricuspid valve surgery through mini-thoracotomy in patients with drug addiction
Objective. To evaluate the effectiveness of erector spinae plane block for tricuspid valve surgery through mini-thoracotomy in patients with drug addiction. Material and methods. A prospective single-center randomized trial included 20 patients after tricuspid valve surgery for infective endocarditis. Mean age was 31.5 [26; 37] years. There were 16 men and 4 women. Tricuspid valve replacement for endocarditis was performed in 4 patients, tricuspid valve excision due to endocarditis — in 16 patients. Cardiopulmonary bypass (93 [68; 124] min) was used in all cases. Patients were randomized into 2 groups: group 1 (control group) — standard anesthetic management with inhalation anesthetics, opioid analgesics and muscle relaxants; group 2 (study group) — additional erector spinae plane block with 0.5% ropivacaine 20 ml into fascial compartment of the appropriate muscle. The study included blockade and control of intraoperative and early postoperative parameters. Clinical parameters, VAS scores of pain after tracheal extubation, total intraoperative doses of fentanyl and the need for prolonged infusion of opioid analgesics in early postoperative period were recorded. Results. Erector spinae plane block excluded opioid analgesia from anesthetic management in patients with drug addiction. There were lower VAS scores of postoperative pain over 24 hours and less incidence of respiratory failure. Conclusion. Erector spinae plane block in anesthetic management of cardiac surgery through mini-access in patients with drug addiction can be considered as an effective method of non-opioid analgesia and postoperative management. Further research in this area is required.
- 8 August 2025
- Published by Media Sphere Publishing Group in Russian Journal of Anesthesiology and Reanimatology
- No. 4
Erector spinae plane block for tricuspid valve surgery through mini-thoracotomy in patients with drug addiction
Objective. To evaluate the effectiveness of erector spinae plane block for tricuspid valve surgery through mini-thoracotomy in patients with drug addiction. Material and methods. A prospective single-center randomized trial included 20 patients after tricuspid valve surgery for infective endocarditis. Mean age was 31.5 [26; 37] years. There were 16 men and 4 women. Tricuspid valve replacement for endocarditis was performed in 4 patients, tricuspid valve excision due to endocarditis — in 16 patients. Cardiopulmonary bypass (93 [68; 124] min) was used in all cases. Patients were randomized into 2 groups: group 1 (control group) — standard anesthetic management with inhalation anesthetics, opioid analgesics and muscle relaxants; group 2 (study group) — additional erector spinae plane block with 0.5% ropivacaine 20 ml into fascial compartment of the appropriate muscle. The study included blockade and control of intraoperative and early postoperative parameters. Clinical parameters, VAS scores of pain after tracheal extubation, total intraoperative doses of fentanyl and the need for prolonged infusion of opioid analgesics in early postoperative period were recorded. Results. Erector spinae plane block excluded opioid analgesia from anesthetic management in patients with drug addiction. There were lower VAS scores of postoperative pain over 24 hours and less incidence of respiratory failure. Conclusion. Erector spinae plane block in anesthetic management of cardiac surgery through mini-access in patients with drug addiction can be considered as an effective method of non-opioid analgesia and postoperative management. Further research in this area is required.